Joost de Bruijn
Qualifications: BSc, PhD
Date of appointment: 2017
Joost de Bruijn, PhD, FBSE, is currently Chief Executive Officer of Kuros Biosciences AG (SIX: KURN). He also holds the position of Professor of Biomaterials at Queen Mary University of London, UK (since 2004) and until recently was Professor of Regenerative Medicine and Entrepreneurship at Twente University, The Netherlands (from 2011-2019). Professor de Bruijn is the founder and CEO of Xpand Biotechnology B.V. that was acquired by Kuros Biosciences AG early 2017 and prior to this was involved with Progentix Orthobiology BV (founder and CEO) that was acquired by NuVasive Inc., Scinus Cell Expansion BV (founder and CEO) and IsoTis Orthobiologics NV.
Dr. de Bruijn has more than 28 years of experience in academia and the life science industry and has brought several technologies to the clinic. He is author on close to 200 peer-reviewed publications and an inventor of 35 patents and patent families. Dr. de Bruijn is scientific editor of the world’s first open-access journal, European Cells and Materials, and reviewer for numerous international biomaterials, tissue engineering and regenerative medicine journals. He received his PhD Cum Laude from Leiden University in 1993 and is a citizen of The Netherlands.
Fancy working with Kuros?
Send us your details and we will be in touch...GET IN TOUCH